BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time

2 months ago

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"…

Rise Health Nano Optics Granted Third U.S. Patent for Breakthrough Nano-Optic Technology Advancing Preventative Vision Care

2 months ago

Vancouver, British Columbia--(Newsfile Corp. - November 4, 2025) - Rise Health Nano Optics Inc. ("Rise" or the "Company"), a health…

Elsevier’s global survey of 3,000 researchers reveals less than half have time to do research but see AI as transformative if given right tools

2 months ago

The Researcher of the Future report highlights increased adoption of AI alongside concerns, regional variations and new mobility trends LONDON,…

“Nobel Prize in Neurosurgery” Winner Dr. Aaron Cohen-Gadol Launches Revolutionary AI Platform Covering 35 Medical Specialties

2 months ago

ATLAS GPT Brings Award-Winning Surgical Excellence to Transform Clinical Decision-Making Across All Healthcare Disciplines LOS ANGELES, Nov. 4, 2025 /PRNewswire/…

Coalition for Patient Rights Announces Update on Their Inaugural Hoedown Nov. 15; Lead-Up Performance by Country Artist Jonny Hazard at Downtown Container Park Nov. 5

2 months ago

Toy drive with Operation Warm Heart benefits Airmen at Nellis & Creech AFBs; Family fun, food, spirits and beverages made…

Equitech-Bio Extends Global Reach With Bioz Badges, Showcasing Citation Engagement From Researchers

2 months ago

PALO ALTO, CA / ACCESS Newswire / November 4, 2025 / Bioz, Inc., the leader in turning scientific literature into…

BioNxt Reports “Intention to Grant” Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies

2 months ago

VANCOUVER, BC / ACCESS Newswire / November 4, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased…

Defence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models

2 months ago

Montreal, Quebec--(Newsfile Corp. - November 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the…

Cellbxhealth PLC Announces Expert Consensus on CTCs; Update on Funding

2 months ago

Independent Expert Consensus Confirms Clinical Relevance of CTCs and Identifies Parsortix Platform as Leading Next-Generation TechnologyExpert consensus predicts integration of…

CardioComm Terminates Royalty Agreement and Enters into $512,000 Insider Loan Facility to Advance Gems Flex and 14-Day Holter/LTCM Platform

2 months ago

Toronto, Ontario--(Newsfile Corp. - November 4, 2025) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical…